Your browser doesn't support javascript.
loading
Extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in Mangodara district, Burkina Faso.
Traore, Adama; Donovan, Laura; Sawadogo, Benoit; Ward, Charlotte; Smith, Helen; Rassi, Christian; Counihan, Helen; Johansson, Johanna; Richardson, Sol; Savadogo, Justin Ragnessi; Baker, Kevin.
Afiliación
  • Traore A; Malaria Consortium, Ouagadougou, Burkina Faso.
  • Donovan L; Malaria Consortium, London, UK. l.donovan@malariaconsortium.org.
  • Sawadogo B; Malaria Consortium, Ouagadougou, Burkina Faso.
  • Ward C; London School of Hygiene & Tropical Medicine, London, UK.
  • Smith H; International Health Consulting Services Ltd, Hoylake, UK.
  • Rassi C; Malaria Consortium, London, UK.
  • Counihan H; Malaria Consortium, London, UK.
  • Johansson J; Malaria Consortium, Lomé, Togo.
  • Richardson S; Malaria Consortium, London, UK.
  • Savadogo JR; Ministry of Health, Ouagadougou, Burkina Faso.
  • Baker K; Malaria Consortium, London, UK.
BMC Public Health ; 22(1): 442, 2022 03 05.
Article en En | MEDLINE | ID: mdl-35247990
ABSTRACT

BACKGROUND:

Seasonal malaria chemoprevention (SMC) involves administering antimalarial drugs at monthly intervals during the high malaria transmission period to children aged 3 to 59 months as recommended by the World Health Organization. Typically, a full SMC course is administered over four monthly cycles from July to October, coinciding with the rainy season. However, an analysis of rainfall patterns suggest that the malaria transmission season is longer and starting as early as June in the south of Burkina Faso, leading to a rise in cases prior to the first cycle. This study assessed the acceptability and feasibility of extending SMC from four to five cycles to coincide with the earlier rainy season in Mangodara health district.

METHODS:

The mixed-methods study was conducted between July and November 2019. Quantitative data were collected through end-of-cycle and end-of-round household surveys to determine the effect of the additional cycle on the coverage of SMC in Mangodara. The data were then compared with 22 other districts where SMC was implemented by Malaria Consortium. Eight focus group discussions were conducted with caregivers and community distributors and 11 key informant interviews with community, programme and national-level stakeholders. These aimed to determine perceptions of the acceptability and feasibility of extending SMC to five cycles.

RESULTS:

The extension was perceived as acceptable by caregivers, community distributors and stakeholders due to the positive impact on the health of children under five. However, many community distributors expressed concern over the feasibility, mainly due to the clash with farming activities in June. Stakeholders highlighted the need for more evidence on the impact of the additional cycle on parasite resistance prior to scale-up. End-of-cycle survey data showed no difference in coverage between five SMC cycles in Mangodara and four cycles in the 22 comparison districts.

CONCLUSIONS:

The additional cycle should begin early in the day in order to not coincide with the agricultural activities of community distributors. Continuous sensitisation at community level is critical for the sustainability of SMC and acceptance of an additional cycle, which should actively engage male caregivers. Providing additional support in proportion to the increased workload from a fifth cycle, including timely remuneration, is critical to avoid the demotivation of community distributors. Further studies are required to understand the effectiveness, including cost-effectiveness, of tailoring SMC according to the rainy season. Understanding the impact of an additional cycle on parasite resistance to SPAQ is critical to address key informants' concerns around the deviation from the current four-cycle policy recommendation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Malaria / Antimaláricos Tipo de estudio: Qualitative_research Límite: Child / Humans / Infant / Male País/Región como asunto: Africa Idioma: En Revista: BMC Public Health Asunto de la revista: SAUDE PUBLICA Año: 2022 Tipo del documento: Article País de afiliación: Burquina Faso

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Malaria / Antimaláricos Tipo de estudio: Qualitative_research Límite: Child / Humans / Infant / Male País/Región como asunto: Africa Idioma: En Revista: BMC Public Health Asunto de la revista: SAUDE PUBLICA Año: 2022 Tipo del documento: Article País de afiliación: Burquina Faso